Matrixome

About:

Matrixome is a biotechnology company that specializes in the research and manufacturing of matrixosome products.

Website: http://www.matrixome.co.jp/

Twitter/X: matrixome

Top Investors: SMBC Venture Capital, Osaka University Venture Capital, Nippi

Description:

Matrixome is a nature, behavior, and fate of cells in a living body are determined by the interaction between cells and the extracellular environment, and is a coined word proposed by Professor Kiyotoshi Sekiguchi, Institute for Protein Research, Osaka University, as a concept that refers to the entire interaction.

Total Funding Amount:

275M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suita, Osaka, Japan

Founded Date:

2015-12-03

Founders:

Kiyotoshi Sekiguchi

Number of Employees:

11-50

Last Funding Date:

2016-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai